sur Revolune
Revolune and MindPeak Collaborate for AACR 2026 Showcase
Revolune GmbH and MindPeak are set to present an integrated workflow at the AACR Annual Meeting 2026, combining multiplex immunofluorescence (mIF) reagents with AI-powered image analysis. This collaboration aims to simplify spatial biology workflows that are crucial for understanding tumor biology and biomarker context.
The integrated approach merges Revolune's advanced mIF reagents and MindPeak's AI-driven software to facilitate the generation of high-quality multiplex tissue data. This offers a streamlined process for researchers, from staining to actionable biological insights.
"Bridging the gap in spatial biology requires robust workflow and data analysis," said Florian Leiss, CEO of Revolune. MindPeak's CEO, Felix Faber, echoed this sentiment, highlighting the reduced barriers to workflow adoption.
Attendees of AACR 2026 can visit booth 1660 to learn about these advancements and their implications for cancer research.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Revolune